Time for some extremely good news: the cures for catastrophic diseases like cancer, Parkinson’s, heart disease and HIV are ...

Sangamo (SGMO) stock faces challenges as Pfizer terminates partnership for hemophilia A gene therapy, impacting share price ...

A source close to the toy industry has leaked a copy of Santa’s perks list for Wisconsin politicians, business leaders and ...

Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the ...

Recently AbbVie closed its acquisition of Aliada Therapeutics, including a promising Alzheimer's disease candidate, for $1.4 ...

Recently AbbVie closed its acquisition of Aliada Therapeutics, including a promising Alzheimer's disease candidate, for $1.4 billion in cash. And it announced that it will buy out Nimble ...

Pfizer PFE issued its financial guidance for 2025. Sanofi SNY and Teva Pharmaceutical’s TEVA inflammatory bowel disease (IBD) ...

BioAge Labs secured a multiyear partnership with Novartis that could total nearly $550 million. Gilead Sciences and Terray Therapeutics entered into a strategic collaboration to discover and develop ...

AbbVie, a global pharmaceutical company headquartered in North Chicago, is acquiring Madison-based Nimble Therapeutics for $200 million in cash, the companies said in a news release. AbbVie has ...